ID: ALA4081306

Max Phase: Preclinical

Molecular Formula: C41H58Cl4N12O3

Molecular Weight: 762.96

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCOc1c2cc(NC(=N)N)cc1Cc1cc(NC(=N)N)cc(c1OCCC)Cc1cc(NC(=N)N)cc(c1OCCC)Cc1cc(cc(NC(=N)N)c1)C2.Cl.Cl.Cl.Cl

Standard InChI:  InChI=1S/C41H54N12O3.4ClH/c1-4-7-54-35-25-11-23-10-24(14-31(13-23)50-38(42)43)12-26-18-33(52-40(46)47)20-28(36(26)55-8-5-2)16-30-22-34(53-41(48)49)21-29(37(30)56-9-6-3)15-27(35)19-32(17-25)51-39(44)45;;;;/h10,13-14,17-22H,4-9,11-12,15-16H2,1-3H3,(H4,42,43,50)(H4,44,45,51)(H4,46,47,52)(H4,48,49,53);4*1H

Standard InChI Key:  YWLKDYBUEMMXQU-UHFFFAOYSA-N

Associated Targets(Human)

Toll-like receptor 4/MD-2/CD14 27 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Toll-like receptor 4 970 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Toll-like receptor 4/MD-2/CD14 6 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 762.96Molecular Weight (Monoisotopic): 762.4442AlogP: 5.95#Rotatable Bonds: 13
Polar Surface Area: 275.29Molecular Species: NEUTRALHBA: 7HBD: 12
#RO5 Violations: 3HBA (Lipinski): 15HBD (Lipinski): 16#RO5 Violations (Lipinski): 4
CX Acidic pKa: CX Basic pKa: 5.60CX LogP: 6.43CX LogD: 6.42
Aromatic Rings: 4Heavy Atoms: 56QED Weighted: 0.05Np Likeness Score: 0.11

References

1. Sestito SE, Facchini FA, Morbioli I, Billod JM, Martin-Santamaria S, Casnati A, Sansone F, Peri F..  (2017)  Amphiphilic Guanidinocalixarenes Inhibit Lipopolysaccharide (LPS)- and Lectin-Stimulated Toll-like Receptor 4 (TLR4) Signaling.,  60  (12): [PMID:28471658] [10.1021/acs.jmedchem.7b00095]

Source